Executive Board

The Executive Board (EB) is appointed by the Supervisory Board and consists of seven members drawn from the various "blood groups" that partner within TI Pharma.

Chair:

• Professor Daan J.A. Crommelin, PhD, Professor in Biopharmaceutics, Utrecht University, Vice Chair scientific committee of IMI

Representing large industrial partners:

• Professor Jan A.M. Raaijmakers, PhD, Vice President External Scientific Collaborations Europe, GlaxoSmithKline Pharmaceuticals

Representing small- and medium-sized industrial partners:

• Frank Leemhuis, PhD, Managing Director of Mercachem
• Hans G.C.P. Schikan, PharmD, Chief Executive Officer Prosensa

Representing academic partners:

• Professor Lou F.M.H. de Leij, PhD, Head of the department of Medical Biology and Dean University Medical Center Groningen
• Professor Meindert Danhof, PhD, Professor of Pharmacology and Director of Research, Leiden/Amsterdam Center for Drug Research
• Professor Hans (J.) C. Stoof, PhD, Professor of Neurology, former Rector Magnificus Utrecht University